CD68 and neoplasm: Whilst Juzentaihoto alone did not significantly alter CD68+ macrophage infiltration, we observed an increase upon Gemcitabine treatment, especially at the tumor border, which was even higher in the Gem/Juz combination treatment (Figure 3A).